ArticleFrontiers in nutrition2026
Factors associated with dietary supplement use among physically active adults in Saudi Arabia: an analytical extension of a population-based study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dietary supplement (DS) use is common among physically active individuals, but evidence on factors associated with DS use and related behaviors in Saudi Arabia remains limited. This study represents the second stage of a two-part investigation among physically active adults in the Eastern Province of Saudi Arabia. Part I described the prevalence and general patterns of DS use, whereas Part II examined factors associated with DS use, supplementation frequency, self-reported adverse effects, and nutritional fact-label reading. Methods: A cross-sectional study was conducted among 755 physically active adults (379 males and 376 females) recruited by quota sampling. Part II was a secondary analysis of the same dataset and the same participants included in Part I. Data were collected from November 2023 to January 2024. Participants were Saudi nationals aged 18-60 years who had engaged in physical activity for at least 12 consecutive weeks, provided informed consent, and completed the questionnaire. A validated online questionnaire assessed sociodemographic characteristics, physical activity, DS use and practices, self-reported adverse effects, purchase sources, perceived metabolic enhancement (categorized according to the self-reported percentage of improvement), and nutritional fact-label reading. DS use referred to consumption of at least one dietary supplement during the previous year. A four-category multinomial outcome represented sex-specific DS-use status, with female non-users as the reference category. Multinomial and binary logistic regression models were used to identify factors associated with DS use, supplementation frequency, adverse effects, and label-reading behavior. Results: Overall, 505 participants (66.9%) reported using at least one DS during the previous year. Although DS use was similarly prevalent among men and women, associated factors differed by sex. Among women, DS use was associated with fitness-, strength-, and cardio-oriented activities, whereas among men it was associated with training frequency and employment status. Supplementation frequency was associated with training frequency, age, sex, and post-exercise recovery. Self-reported adverse effects were associated with younger age and internet purchasing, while nutritional fact-label reading was associated with female sex, public-sector employment, and greater perceived metabolic enhancement. Conclusions: DS use is common among physically active individuals in Saudi Arabia and is associated with sex-specific, behavioral, and sociodemographic characteristics. These findings emphasize the multifaceted nature of supplementation practices and support targeted, evidence-based strategies to promote informed and safe DS use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.